|
Breaking News: Report in the Journal of American Medical Association Finds Older Patients using Avandia at Risk of Serious Heart Problems, Death
BREAKING NEWS: A study in the December 12, 2007 issue of the Journal of the American Medical Association (JAMA) has found that older patients treated with diabetes medications known as thiazolidinediones (which include rosiglitazone, brand name Avandia) had a significantly increased risk of heart attack, congestive heart failure and death, compared with the use of other drugs.
The study's authors conclude that the results present further evidence that drugs such as Avandia may cause more harm than good.
The study included 159,026 individuals with diabetes. Users of medicines with rosiglitazone had a 60 percent increased risk of heart failure; a 40 percent increased risk of heart attack; and a 29 percent increased risk of death.
If you or a loved one has suffered cardiac complications after ingesting Avandia, you deserve the guidance of a knowledgeable drug attorney. Get a free case review by filling out the form below.
see also:
6.6.07 Study
Study Designed to Debunk Risks Raises Questions About Avandia MedicineAvandia Medicine Still Has Serious Heart Risks, Doctors Warn
Black Box Warning
FDA: Manufacturer of Avandia Strengthens Warning on Heart Failure RiskFDA Says GlaxoSmithKline Will Include Boxed Warning on Avandia Label
FDA Warning, 6.6.07
FDA Issues Strictest Warning on Prescription Diabetes Drug AvandiaFDA Calls for Toughest Warning to be Placed on Avandia Prescription
